Taiwan MCU factory is optimistic about the medical electronics market
The medical electronics market is expected to grow strongly and will become one of the main driving forces for the growth of domestic microcontroller (MCU) plants in recent years.
According to the development of IC Insights, the global medical electronics market is expected to resume strong growth momentum in 2010 due to the weak global economy and the slowdown in health care costs in Europe and the United States.
IC Insights estimates that the global medical electronics market will have an output value of about 47.3 billion U.S. dollars this year, which will increase by 3%. Next year, the global medical electronics market is expected to climb to 50.9 billion U.S. dollars, up 8% from this year.
This year's medical system semiconductor output value will be about 4.4 billion US dollars, an annual increase of 7%, IC Insights is optimistic, next year medical system semiconductor output value is expected to reach 4.9 billion US dollars, will grow 12% stronger than this year.
IC Insights expects global medical electronics output to reach US$65.4 billion in 2017 and a compound growth rate of 7.3% from 2012 to 2017. In 2017, the medical system semiconductor output will reach US$6.8 billion, and the compound growth rate from 2012 to 2017. Up to 10.5%.
Optimistic about the prospects of the medical electronics market, Taiwan MCU operators such as Sheng Qun, Song Han, Xin Tang and Wei Quan Electric, including the sphygmomanometer, blood glucose meter, thermometer and body fat scale, etc.
Among them, Shengqun has shipped 15 million sets of medical MCU products in the first three quarters of this year, approaching 17.6 million sets in the previous year, and shipments have grown steadily; medical products accounted for about 11% of the total MCU.
The remaining Songhan, Xintang and Weiquan medical MCU shipments also grew steadily.
As the global medical electronics market continues to grow, MCU plant operations are expected to benefit, and future medical MCU product shipments will continue to grow.
In addition to medical MCU products, Holtek also had a good market in mobile power, touch buttons and financial markets, which led to a consolidated revenue of NT$3.575 billion in the first 11 months of this year, an increase of 8.26% over the same period last year.
Holtek is optimistic that next year, driven by the simultaneous growth of medical and mobile power and financial products, the performance is expected to rise to the next level and continue its growth trend.
The application of Songhan wireless audio and video module products is also expanding, which has slowed down the demand for notebook computer market. The consolidated revenue of the previous November was 3.339 billion yuan, an increase of 1.68%. This year's performance is expected to rebound.
Although Xintang has successfully expanded its 32-bit MCU product market, its shipments in the first 11 months have exceeded 30 million sets, a record high, but the proportion of personal computer products is still high. The operation continues to be affected by the poor market conditions of the computer. Revenue was 6.31 billion yuan, down 8.45% year-on-year, and the performance was relatively unsatisfactory.
Weiquan Electric successfully expanded its power management chip market into the game console application market and rushed into the mainland China's end-point sales system market. Its own product shipments grew and led to profitability.
Weizheng Electric's consolidated revenue in November was 1.68 billion yuan, although it was 7.93% lower than the same period of last year. However, the net profit after tax for the first three quarters was 97.53 million yuan, and the net profit per share was 0.4 yuan, which was a big increase of 3.8 million over the whole year. Times.
We are a professional peptide product manufacturer with productive factory, which is able to produce API and petide product intermediate with reliable quality and good price. Our advantage peptide products:
Custom Peptide modification
Custom Peptides / Peptides Synthesis
Generic Peptides API
Pharmaceutical Peptide
Comstic Peptides
Special Amino Acids
Reaent for Peptides
Most of our products meet EP and USP standards, can be widely used in biochemical Research,Immunology, Histology and as Active Pharmaceutical Ingredients (API).With more than 20 experienced R&D technicians, who with over 10 years experience in peptide chemistry and other related research areas; one R&D center and one GMP standard workshop. Welcome to contact us.
Generic Peptide APIS,Cosmetic Peptides,GMP Peptides,Custom Peptides,Peptide Synthesis Pharmaceutical Peptides
Taizhou Volsen Chemical Co., Ltd. , https://www.volsenchem.com